🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, fluticasone furoate (FF) and vilanterol (VI) in different do...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-12-05
Trial ID
NCT01711463
Treatments Being Tested
To investigate the validity of a clinical model to determine the relative p...
Status
Completed
Location
Firestone Institute for Respiratory Health, St. Joseph's Healthcare
Start Date
2001-01
Trial ID
NCT00292838
Treatments Being Tested
This is a randomized, double-blind, placebo- and open-label active controll...
Status
Completed
Location
Teva Investigational Site 10165
Start Date
2012-01
Trial ID
NCT01479621
Treatments Being Tested
Asthma is a common, chronic respiratory disease affecting 1-18 percent of t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-01-18
Trial ID
NCT03376932
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
The purpose of this study is to demonstrate dose proportionality of flutica...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-10-04
Trial ID
NCT01213849
The primary objective of the study is to evaluate the long-term safety of f...
Status
Completed
Location
Teva Investigational Site 12068
Start Date
2014-07
Trial ID
NCT02175771
Treatments Being Tested
The objective of the current study is to investigate the efficacy, safety a...
Status
Completed
Location
1268.41.49001 Boehringer Ingelheim Investigational Site
Start Date
2009-10
Trial ID
NCT01007721
Treatments Being Tested
The primary objective of this study was to evaluate the efficacy of flutica...
Status
Completed
Location
Teva Investigational Site 12397
Start Date
2014-06
Trial ID
NCT02139644
Treatments Being Tested
A once-daily 'closed' triple FDC therapy of FF/UMEC/VI via a single ELLIPTA...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10-13
Trial ID
NCT02924688